Randy H Thurman - Net Worth and Insider Trading
Randy H Thurman Net Worth
The estimated net worth of Randy H Thurman is at least $658,477 dollars as of 2024-11-13. Randy H Thurman is the Director of Veradigm Inc and owns about 58,905 shares of Veradigm Inc (MDRX) stock worth over $654,435. Randy H Thurman is the Director of Outlook Therapeutics Inc and owns about 594 shares of Outlook Therapeutics Inc (OTLK) stock worth over $3,724. Randy H Thurman is also the Executive Chairman of Presbia PLC and owns about 21,229 shares of Presbia PLC (LENSF) stock worth over $318. Besides these, Randy H Thurman also holds Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) . Details can be seen in Randy H Thurman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randy H Thurman has not made any transactions after 2022-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randy H Thurman
Randy H Thurman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randy H Thurman owns 6 companies in total, including Outlook Therapeutics Inc (OTLK) , TFF Pharmaceuticals Inc (TFFP) , and Veradigm Inc (MDRX) among others .
Click here to see the complete history of Randy H Thurman’s form 4 insider trades.
Insider Ownership Summary of Randy H Thurman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2020-09-14 | director |
| TFFP | TFF Pharmaceuticals Inc | 2022-09-29 | director |
| MDRX | Veradigm Inc | 2014-11-11 | director |
 | | 2017-03-13 | director & Executive Chairman |
| | 2014-01-24 | director |
| | 2013-11-05 | director |
Randy H Thurman Latest Holdings Summary
Randy H Thurman currently owns a total of 5 stocks. Among these stocks, Randy H Thurman owns 58,905 shares of Veradigm Inc (MDRX) as of November 11, 2014, with a value of $654,435 and a weighting of 99.39%. Randy H Thurman owns 594 shares of Outlook Therapeutics Inc (OTLK) as of September 14, 2020, with a value of $3,724 and a weighting of 0.57%. Randy H Thurman also owns 21,229 shares of Presbia PLC (LENSF) as of November 25, 2015, with a value of $318 and a weighting of 0.05%. The other 2 stocks Arno Therapeutics Inc (ARNI) , TFF Pharmaceuticals Inc (TFFP) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Randy H Thurman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDRX | Veradigm Inc | 2014-11-11 | 58,905 | 11.11 | 654,435 |
| OTLK | Outlook Therapeutics Inc | 2020-09-14 | 594 | 6.27 | 3,724 |
| LENSF | Presbia PLC | 2015-11-25 | 21,229 | 0.02 | 318 |
| ARNI | Arno Therapeutics Inc | 2013-05-22 | 1,250 | 0.00 | 0 |
| TFFP | TFF Pharmaceuticals Inc | 2022-09-29 | 0 | 1.81 | 0 |
Holding Weightings of Randy H Thurman
Randy H Thurman Form 4 Trading Tracker
According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Veradigm Inc (MDRX) over the past 5 years. The most-recent trade in Veradigm Inc is the acquisition of 8,849 shares on November 11, 2014, which cost Randy H Thurman around $99,905.
According to the SEC Form 4 filings, Randy H Thurman has made a total of 1 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 500 shares on September 14, 2020, which cost Randy H Thurman around $6,200.
According to the SEC Form 4 filings, Randy H Thurman has made a total of 0 transactions in Presbia PLC (LENSF) over the past 5 years. The most-recent trade in Presbia PLC is the acquisition of 1,833 shares on November 25, 2015, which cost Randy H Thurman around $9,990.
More details on Randy H Thurman's insider transactions can be found in the Insider Trading History of Randy H Thurman table.Insider Trading History of Randy H Thurman
- 1
Randy H Thurman Trading Performance
GuruFocus tracks the stock performance after each of Randy H Thurman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randy H Thurman is 6.45%. GuruFocus also compares Randy H Thurman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randy H Thurman within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randy H Thurman's insider trading performs compared to the benchmark.
Performance of Randy H Thurman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.14 | | | | | |
| Relative Return to S&P 500(%) | 3.53 | | | | | |
Randy H Thurman Ownership Network
Ownership Network List of Randy H Thurman
Ownership Network Relation of Randy H Thurman
Randy H Thurman Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Randy H Thurman is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Randy H Thurman made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Randy H Thurman Mailing Address
Above is the net worth, insider trading, and ownership report for Randy H Thurman. You might contact Randy H Thurman via mailing address: 222 Merchandise Mart Plaza, Suite 2024, Chicago Il 60654.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
